EQRIVY Trademark

Trademark Overview

On Monday, October 5, 2020, a trademark application was filed for EQRIVY with the United States Patent and Trademark Office. The USPTO has given the EQRIVY trademark a serial number of 90236295. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 16, 2024. This trademark is owned by ADC Therapeutics SA. The EQRIVY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology
eqrivy

General Information

Serial Number90236295
Word MarkEQRIVY
Filing DateMonday, October 5, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 21, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 19, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameADC Therapeutics SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressEpalinges 1066
CH
Party NameADC Therapeutics SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressEpalinges 1066
CH

Trademark Events

Event DateEvent Description
Thursday, October 8, 2020NEW APPLICATION ENTERED
Thursday, November 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 2, 2021ASSIGNED TO EXAMINER
Wednesday, February 3, 2021NON-FINAL ACTION WRITTEN
Wednesday, February 3, 2021NON-FINAL ACTION E-MAILED
Wednesday, February 3, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 20, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 20, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 18, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 21, 2021PUBLISHED FOR OPPOSITION
Tuesday, September 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 21, 2022SOU TEAS EXTENSION RECEIVED
Monday, March 21, 2022SOU EXTENSION 1 FILED
Monday, March 21, 2022SOU EXTENSION 1 GRANTED
Wednesday, March 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 20, 2022SOU TEAS EXTENSION RECEIVED
Thursday, October 20, 2022SOU EXTENSION 2 FILED
Thursday, October 20, 2022SOU EXTENSION 2 GRANTED
Saturday, October 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 22, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, March 22, 2023SOU EXTENSION 3 FILED
Wednesday, March 22, 2023SOU EXTENSION 3 GRANTED
Friday, March 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 15, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 15, 2023SOU EXTENSION 4 FILED
Wednesday, November 15, 2023SOU EXTENSION 4 GRANTED
Friday, November 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 14, 2024SOU EXTENSION 5 FILED
Tuesday, May 14, 2024SOU EXTENSION 5 GRANTED
Tuesday, May 14, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 16, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 16, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

eqrivy pharmaceutical preparations oncology treatment cancer